Sarepta Therapeutics | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 182.88M 30.27M 2024-03
Agios Pharmaceuticals USD 7.56M 1.04M 2024-03
Alnylam Pharmaceuticals USD 428.36M 74.5M 2024-03
Amgen USD 4.25B 837M 2024-03
Biogen USD 1.75B 19.7M 2024-03
BioMarin Pharmaceutical USD 523.65M 12.92M 2024-03
Daiichi Sankyo JPY 324.58B 43.81B 2023-12
Eli Lilly USD 7.09B 470.9M 2024-03
Gilead Sciences USD 5.13B 370M 2024-03
Incyte USD 819.89M 129.4M 2024-03
Insmed USD 58.04M 7.21M 2024-03
Ionis Pharmaceuticals USD 117.35M 204.1M 2024-03
Moderna USD 71M 1.81B 2024-03
Neurocrine Biosciences USD 507.8M 20.2M 2024-03
Pfizer USD 11.5B 3.92B 2024-03
PTC Therapeutics USD 195.38M 82.56M 2024-03
Regeneron Pharmaceuticals USD 2.71B 206.1M 2024-03
Roche Holding CHF 22.16B 123M 2023-06
Sanofi EUR 7.68B 1.18B 2024-03
Sarepta Therapeutics USD 362.9M 68.11M 2024-03
Ultragenyx Pharmaceutical USD 91.3M 24.04M 2024-03
Vertex Pharmaceuticals USD 2.35B 183.2M 2024-03



Sarepta Therapeutics Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.